https://ir.scorpiusbiologics.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_e5615c5985766712c2225b8c9eb16945/scorpiusbiologics/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.scorpiusbiologics.com/news-events/press-releases/detail/781/scorpius-holdings-announces-corporate-update-including-cost-optimization-initiatives-strategic-corporate-developments-and-potential-opportunities-for-expansion-into-southeast-asia Mon, 05 May 25 08:00:00 -0400 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/781/scorpius-holdings-announces-corporate-update-including-cost-optimization-initiatives-strategic-corporate-developments-and-potential-opportunities-for-expansion-into-southeast-asia https://ir.scorpiusbiologics.com/news-events/press-releases/detail/780/scorpius-holdings-provides-2024-year-end-business-update-implements-strategic-cost-reductions-and-operational-streamlining Wed, 30 Apr 25 16:05:00 -0400 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/780/scorpius-holdings-provides-2024-year-end-business-update-implements-strategic-cost-reductions-and-operational-streamlining https://ir.scorpiusbiologics.com/news-events/press-releases/detail/779/scorpius-holdings-receives-nyse-american-notice-of-delisting-and-reports-plans-to-appeal Mon, 21 Apr 25 20:00:00 -0400 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/779/scorpius-holdings-receives-nyse-american-notice-of-delisting-and-reports-plans-to-appeal https://ir.scorpiusbiologics.com/news-events/press-releases/detail/778/scorpius-holdings-engages-alliance-global-partners-to-explore-strategic-alternatives Wed, 26 Feb 25 08:30:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/778/scorpius-holdings-engages-alliance-global-partners-to-explore-strategic-alternatives https://ir.scorpiusbiologics.com/news-events/press-releases/detail/777/scorpius-holdings-announces-collaboration-with-kalocyte-to-advance-manufacturing-for-erythromer Wed, 22 Jan 25 08:30:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/777/scorpius-holdings-announces-collaboration-with-kalocyte-to-advance-manufacturing-for-erythromer https://ir.scorpiusbiologics.com/news-events/press-releases/detail/776/scorpius-holdings-cancels-planned-reverse-stock-split Fri, 17 Jan 25 15:13:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/776/scorpius-holdings-cancels-planned-reverse-stock-split https://ir.scorpiusbiologics.com/news-events/press-releases/detail/775/scorpius-holdings-announces-reverse-stock-split Thu, 16 Jan 25 16:05:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/775/scorpius-holdings-announces-reverse-stock-split https://ir.scorpiusbiologics.com/news-events/press-releases/detail/774/scorpius-holdings-launches-scorpius-ventures-to-support-u-s-biotech-innovation-through-flexible-equity-based-onshoring-model Tue, 19 Nov 24 07:30:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/774/scorpius-holdings-launches-scorpius-ventures-to-support-u-s-biotech-innovation-through-flexible-equity-based-onshoring-model https://ir.scorpiusbiologics.com/news-events/press-releases/detail/773/scorpius-holdings-reports-third-quarter-2024-results-highlighting-strategic-partnerships-cost-savings-and-progress-toward-profitability Thu, 14 Nov 24 16:15:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/773/scorpius-holdings-reports-third-quarter-2024-results-highlighting-strategic-partnerships-cost-savings-and-progress-toward-profitability https://ir.scorpiusbiologics.com/news-events/press-releases/detail/772/scorpius-holdings-announces-collaboration-with-celltheon-corporation-a-u-s--based-cell-line-development-company-first-client-signed-under-new-partnership-agreement Mon, 04 Nov 24 07:30:00 -0500 https://ir.scorpiusbiologics.com/news-events/press-releases/detail/772/scorpius-holdings-announces-collaboration-with-celltheon-corporation-a-u-s--based-cell-line-development-company-first-client-signed-under-new-partnership-agreement